Gratitude is shared for the contributions of hosts and individuals in the field. The discussion highlights challenges in cancer treatment, particularly the high costs and low value of many drugs. Solutions are needed, including price reductions and better drug efficacy. Dosing strategies, especially low and ultra-low doses, show promise, supported by clinical trial data. The future of optimization studies in India is bright, with a call to action for improved patient treatment.